Patents by Inventor Goetz R. A. Ehrhardt

Goetz R. A. Ehrhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8212018
    Abstract: Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs).
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: July 3, 2012
    Assignee: The UAB Research Foundation
    Inventors: Zeev Pancer, Max D. Cooper, Chris Amemiya, G. Larry Gartland, Goetz R. A. Ehrhardt
  • Publication number: 20120107929
    Abstract: Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs).
    Type: Application
    Filed: September 9, 2011
    Publication date: May 3, 2012
    Applicants: BENAROYA RESEARCH INSTITUTE, THE UAB RESEARCH FOUNDATION
    Inventors: Zeev Pancer, Max D. Cooper, Chris Amemiya, G. Larry Gartland, Goetz R. A. Ehrhardt
  • Patent number: 8039588
    Abstract: Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs).
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: October 18, 2011
    Assignees: The UAB Research Foundation, Benaroya Research Institute
    Inventors: Zeev Pancer, Max D. Cooper, Chris Amemiya, G. Larry Gartland, Goetz R. A. Ehrhardt
  • Publication number: 20110165584
    Abstract: Disclosed are compositions and methods related to variable lymphocyte receptors (VLRs).
    Type: Application
    Filed: May 23, 2005
    Publication date: July 7, 2011
    Applicants: UAB RESEARCH FOUNDATION, THE, BENAROYA RESEARCH INSTITUTE
    Inventors: Zeev Pancer, Max D. Cooper, Chris Amemiya, G. Larry Gartland, Goetz R. A. Ehrhardt
  • Publication number: 20110086047
    Abstract: Provided herein are antibodies having the same epitope specificity as an antibody produced by the hybridoma cell line deposited with the American Type Culture Collection as hybridoma 4-2A6, 1-5A3, or 1-3B4. Further provided herein are methods of identifying and selecting cells that express FcRH1 or FcRH4. Methods of diagnosing and treating a subject with a malignancy of a hematopoietic cell lineage or an autoimmune disease and methods of modulating a humoral immune response in a subject are also provided herein. Further provided herein are polypeptides comprising one or more complementary determining regions of the disclosed antibodies and nucleic acids that encode the disclosed polypeptides.
    Type: Application
    Filed: May 13, 2010
    Publication date: April 14, 2011
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventors: Randall S. Davis, Max D. Cooper, Chuen-Miin Leu, Goetz R. A. Ehrhardt
  • Publication number: 20080131433
    Abstract: Provided herein are antibodies having the same epitope specificity as an antibody produced by the hybridoma cell line deposited with the American Type Culture Collection as hybridoma 4-2A6, 1-5A3, or 1-3B4. Further provided herein are methods of identifying and selecting cells that express FcRH1 or FcRH4. Methods of diagnosing and treating a subject with a malignancy of a hematopoietic cell lineage or an autoimmune disease and methods of modulating a humoral immune response in a subject are also provided herein. Further provided herein are polypeptides comprising one or more complementary determining regions of the disclosed antibodies and nucleic acids that encode the disclosed polypeptides.
    Type: Application
    Filed: September 27, 2005
    Publication date: June 5, 2008
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventors: Randall S. Davis, Max D. Cooper, Chuen-Miin Leu, Goetz R. Ehrhardt